IMPA2 Blocking Peptide (N-Term)
€363.00
In stock
SKU
AC-BP21697a
Background:
Can use myo-inositol monophosphates, scylloinositol 1,4- diphosphate, glucose-1-phosphate, beta-glycerophosphate, and 2'- AMP as substrates. Has been implicated as the pharmacological target for lithium Li(+) action in brain.
Other Names:
Inositol monophosphatase 2, IMP 2, IMPase 2, Inositol-1(or 4)-monophosphatase 2, Myo-inositol monophosphatase A2, IMPA2, IMP18P
Target/Specificity:
The synthetic peptide sequence is selected from aa 68-82 of HUMAN IMPA2
Gene Name: IMPA2
Gene ID: 3613
Primary Accession: O14732
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Can use myo-inositol monophosphates, scylloinositol 1,4- diphosphate, glucose-1-phosphate, beta-glycerophosphate, and 2'- AMP as substrates. Has been implicated as the pharmacological target for lithium Li(+) action in brain.
Other Names:
Inositol monophosphatase 2, IMP 2, IMPase 2, Inositol-1(or 4)-monophosphatase 2, Myo-inositol monophosphatase A2, IMPA2, IMP18P
Target/Specificity:
The synthetic peptide sequence is selected from aa 68-82 of HUMAN IMPA2
Gene Name: IMPA2
Gene ID: 3613
Primary Accession: O14732
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review